In-store Execution & NBA Delivery Lead

Welcome to Haleon. We’re a purpose-driven, world-class consumer company putting everyday health in the hands of millions. In just three years since our launch, we’ve grown, evolved and are now entering an exciting new chapter – one filled with bold ambitions and enormous opportunity.

Our trusted portfolio of brands – including Sensodyne®, Panadol®, Advil®, Voltaren®, Theraflu®, Otrivin®, and Centrum® – lead in resilient and growing categories. What sets us apart is our unique blend of deep human understanding and trusted science. Now it’s time to fully realise the full potential of our business and our people.

We do this through our Win as One strategy. It puts our purpose – to deliver better everyday health with humanity – at the heart of everything we do. It unites us, inspires us, and challenges us to be better every day, driven by our agile, performance-focused culture.

Background & Programme Context The Commercial Digital Services Value Pool, within Haleon's Digital & Technology Function, represents a major enterprise-wide transformation effort aimed at unlocking more than £250m in commercial benefits over 3–5 years, enabled by over £100m in targeted digital investment. Within this portfolio, the Go To Market Transformation Programme is a strategic multi-year initiative designed to modernise how Haleon engages customers, pharmacies, healthcare professionals and retail partners through digitally enabled commercial capabilities. As consumer expectations evolve and retail e